Capital Income Builder Class 529-A Shares (CIRAX)
This fund typically allocates a minimum of 90% of its capital to income-generating securities. Within this allocation, at least 50% is specifically earmarked for common stocks and other equity instruments. The portfolio broadly encompasses a diverse array of income-producing assets, including both stocks and bonds. Its primary objective is to furnish investors with a current income stream that surpasses the average yield available from U.S. stocks; to achieve this, the fund generally references the average yield of companies listed on the S&P 500 Index.
CIRAX Mutual Fund Chart & Stats
- Previous Close
- $84.39
- Sub-Category
- Asset Allocation
- Total Liabilities
- $2.85B
- Last Dividend Ex-Date
- Sep 14, 2026
- Expense Ratio
- 0.60%
- Holding Count
- 2,766
- Brand
- Capital Income Builder
- Dividend Yield
- (7.06%)
- Category
- Balanced
- Total Assets
- 133.31B
- Shares Outstanding
- N/A
- 52-Week Range
- $76.16 - $88.16
CIRAX Mutual Fund News
AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World Insights and Decision Guidance Evaluation (BRIDGE-HK) An Observational, Retrospective,
Top 10 Holdings
| Name | Weight % |
|---|---|
| USD_CASHCAPITAL GROUP CENTRAL CASH FUND | 4.22% |
| AVGOBroadcom Inc. | 4.02% |
| 2330TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | 3.38% |
| PMPhilip Morris International | 2.94% |
| CCBFXCAPITAL GROUP CENTRAL CORPORATE BOND FUND | 2.04% |
| ABBVAbbvie | 1.93% |
| BATSBritish American Tobacco (UK) | 1.85% |
| RTXRtx Corporation | 1.57% |
| JPMJPMorgan Chase & Co. | 1.17% |
| AZNAstraZeneca plc | 1.10% |
| Total | 24.21% |
Recently Viewed
No data currently available














